UF de Génétique Médicale et Cytogénétique, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.
Centre de Référence du Syndrome de Marfan et des Syndromes Apparentés, Hôpital des Enfants, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Eur J Hum Genet. 2021 May;29(5):771-779. doi: 10.1038/s41431-020-00797-3. Epub 2021 Jan 7.
Marfan syndrome (MFS) is a heritable connective tissue disorder (HCTD) caused by pathogenic variants in FBN1 that frequently occur de novo. Although individuals with somatogonadal mosaicisms have been reported with respect to MFS and other HCTD, the overall frequency of parental mosaicism in this pathology is unknown. In an attempt to estimate this frequency, we reviewed all the 333 patients with a disease-causing variant in FBN1. We then used direct sequencing, combined with High Resolution Melting Analysis, to detect mosaicism in their parents, complemented by NGS when a mosaicism was objectivized. We found that (1) the number of apparently de novo events is much higher than the classically admitted number (around 50% of patients and not 25% as expected for FBN1) and (2) around 5% of the FBN1 disease-causing variants were not actually de novo as anticipated, but inherited in a context of somatogonadal mosaicisms revealed in parents from three families. High Resolution Melting Analysis and NGS were more efficient at detecting and evaluating the level of mosaicism compared to direct Sanger sequencing. We also investigated individuals with a causal variant in another gene identified through our "aortic diseases genes" NGS panel and report, for the first time, on an individual with a somatogonadal mosaicism in COL5A1. Our study shows that parental mosaicism is not that rare in Marfan syndrome and should be investigated with appropriate methods given its implications in patient's management.
马凡综合征(MFS)是一种由 FBN1 中的致病变异引起的遗传性结缔组织疾病(HCTD),这些变异通常是新生的。尽管已经报道了一些患有体细胞性腺嵌合体的 MFS 和其他 HCTD 患者,但这种病理学中父母嵌合体的总体频率尚不清楚。为了尝试估计这种频率,我们回顾了所有 333 名 FBN1 致病变异患者的病例。然后,我们使用直接测序,结合高分辨率熔解分析,来检测其父母的嵌合体,并在客观化嵌合体时使用 NGS 进行补充。我们发现:(1)明显新生事件的数量远高于经典承认的数量(约 50%的患者,而不是预期的 FBN1 中的 25%);(2)约 5%的 FBN1 致病变异实际上并非如预期的那样是新生的,而是在来自三个家庭的父母中的体细胞性腺嵌合体背景下遗传的。与直接 Sanger 测序相比,高分辨率熔解分析和 NGS 更有效地检测和评估嵌合体的水平。我们还研究了另一个通过我们的“主动脉疾病基因”NGS 面板确定的致病基因变异的个体,并首次报道了一个 COL5A1 体细胞性腺嵌合体的个体。我们的研究表明,马凡综合征中父母嵌合体并不罕见,应根据其对患者管理的影响,采用适当的方法进行调查。